Volume 27, Number 12—December 2021
CME ACTIVITY - Research
Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong
Table 1
Year | Adult population | No. cases |
Incidence† |
|||||
---|---|---|---|---|---|---|---|---|
Overall | HA-CDI | CA-CDI | Overall | HA-CDI | CA-CDI | |||
2015 | 6,247,460 | 3,160 | 2,921 | 181 | 50.6 | 46.8 | 2.9 | |
2016 | 6,301,560 | 3,303 | 3,058 | 185 | 52.4 | 48.5 | 2.9 | |
2017 | 6,357,420 | 3,618 | 3,303 | 231 | 56.9 | 52.0 | 3.6 | |
2018 | 6,410,080 | 3,557 | 3,248 | 223 | 55.5 | 50.7 | 3.5 | |
2019 | 6,481,000 | 3,467 | 3,187 | 205 | 53.5 | 49.2 | 3.2 |
*Adult is defined as a person >18 years of age. CA-CDI, community-associated Clostridioides difficile infection; HA-CDI, healthcare-associated Clostridioides difficile infection. †No. cases/100,000 adults.
1These authors contributed equally to this work.
2These authors were co–principal investigators.
Page created: November 17, 2021
Page updated: November 17, 2021
Page reviewed: November 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.